精准评估及个性化干预改善失眠障碍患者失眠缓解率的多中心、非盲、平行对照研究

注册号:

Registration number:

ChiCTR2300074998 

最近更新日期:

Date of Last Refreshed on:

2024-01-18 11:57:50 

注册时间:

Date of Registration:

2023-08-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

精准评估及个性化干预改善失眠障碍患者失眠缓解率的多中心、非盲、平行对照研究

Public title:

A multicenter, unblinded, parallel controlled study on precise evaluation and personalized intervention to improve insomnia relief rate in patients with insomnia disorders

注册题目简写:

English Acronym:

研究课题的正式科学名称:

精准评估及个性化干预改善失眠障碍患者失眠缓解率的多中心、 非盲、平行对照研究

Scientific title:

A multicenter, unblinded, parallel controlled study on precise evaluation and personalized intervention to improve insomnia relief rate in patients with insomnia disorders

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张斌 

研究负责人:

张斌 

Applicant:

Bin Zhang 

Study leader:

Bin Zhang 

申请注册联系人电话:

Applicant telephone:

+86 135 2780 7502

研究负责人电话:

Study leader's
telephone:

+86 135 2780 7502

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhang73bin@hotmail.com

研究负责人电子邮件:

Study leader's E-mail:

zhang73bin@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市白云区广州大道北1838号

研究负责人通讯地址:

广东省广州市白云区广州大道北1838号

Applicant address:

1838 Guangzhou Avenue North, Baiyun District, Guangzhou, Guangdong

Study leader's address:

1838 Guangzhou Avenue North, Baiyun District, Guangzhou, Guangdong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南方医科大学南方医院

Applicant's institution:

Nanfang Hospital of Southern Medical University

研究负责人所在单位:

南方医科大学南方医院

Affiliation of the Leader:

Nanfang Hospital of Southern Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

NFEC-2023-300

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南方医科大学南方医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Nanfang Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-07-07 00:00:00

伦理委员会联系人:

郭志刚

Contact Name of the ethic committee:

Zhigang Guo

伦理委员会联系地址:

广东省广州市白云区广州大道北1838号

Contact Address of the ethic committee:

1838 Guangzhou Avenue North, Baiyun District, Guangzhou, Guangdong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 6278 7238

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南方医科大学南方医院

Primary sponsor:

Nanfang Hospital of Southern Medical University

研究实施负责(组长)单位地址:

广东省广州市白云区广州大道北1838号

Primary sponsor's address:

1838 Guangzhou Avenue North, Baiyun District, Guangzhou, Guangdong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

南方医科大学南方医院

具体地址:

广东省广州市白云区广州大道北1838号

Institution
hospital:

Nanfang Hospital of Southern Medical University

Address:

1838 Guangzhou Avenue North, Baiyun District, Guangzhou, Guangdong

经费或物资来源:

国家重点研发计划-2021YFC2501505

Source(s) of funding:

National Key Research and Development Program of China-2021YFC2501505

研究疾病:

失眠  

Target disease:

Insomnia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

评估患者层面的治疗效果以及治疗满意度、情绪、认知功能、生活质量等情况。  

Objectives of Study:

To evaluate the treatment effectiveness at the patient level, as well as treatment satisfaction, emotions, cognitive function, and quality of life.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

医疗单位: 1.不能通过伦理考试; 2.无法接受定期培训; 3.无法推广和应用新的预防和控制系统。 患者: 1.怀孕或哺乳期妇女; 2.罹患严重智力障碍或躯体疾病; 3.其他不适宜纳入研究的情况。

Exclusion criteria:

Member unit: 1. Unable to pass ethics; 2. Unable to receive regular training; 3. Unable to promote and apply new prevention and control systems. Patient: 1. Pregnant or lactating women; 2. Suffering from severe intellectual disabilities or physical illnesses; 3. Other situations that are not suitable for inclusion in the study.

研究实施时间:

Study execute time:

From 2023-08-23 00:00:00 To 2024-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-08-23 00:00:00 To 2024-10-01 00:00:00

干预措施:

Interventions:

组别:

精准干预组

样本量:

600

Group:

Precision intervention group

Sample size:

干预措施:

干预组患者在维持原有治疗方案的基础上,医生根据分型平台结果推荐患者接受个体化治疗

干预措施代码:

Intervention:

On the basis of maintaining the original treatment plan, the intervention group patients are recommended to receive personalized treatment by doctors based on the results of the classification platform

Intervention code:

组别:

常规治疗组

样本量:

600

Group:

Conventional treatment group

Sample size:

干预措施:

根据患者病情进行临床常规诊疗

干预措施代码:

Intervention:

Choose appropriate clinical diagnosis and treatment plans based on the patient's condition

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

深圳市人民医院 

单位级别:

三甲 

Institution
hospital:

Shenzhen People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

深圳市第二人民医院 

单位级别:

三甲 

Institution
hospital:

Shenzhen Second People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

云南 

市(区县):

 

Country:

China

Province:

Yunnan

City:

单位(医院):

云南省第一人民医院 

单位级别:

三甲 

Institution
hospital:

Yunnan First People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

武汉 

市(区县):

 

Country:

China

Province:

Wuhan

City:

单位(医院):

武汉市第一医院 

单位级别:

三甲 

Institution
hospital:

Wuhan First Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

宁夏 

市(区县):

 

Country:

China

Province:

Ningxia

City:

单位(医院):

宁夏回族自治区宁安医院 

单位级别:

三甲 

Institution
hospital:

Ning'an Hospital of Ningxia

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

贵州 

市(区县):

 

Country:

China

Province:

Guizhou

City:

单位(医院):

贵州省第二人民医院 

单位级别:

三甲 

Institution
hospital:

The Second People's Hospital of Guizhou

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山市第三人民医院 

单位级别:

三甲 

Institution
hospital:

The Third People's Hospital of Zhongshan

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市中医医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Traditional Chinese Medicine Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古 

市(区县):

 

Country:

China

Province:

Neimenggu

City:

单位(医院):

内蒙古自治区第三医院(精神卫生中心) 

单位级别:

三甲 

Institution
hospital:

The Third Hospital of Inner Mongolia Autonomous Region

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

新疆 

市(区县):

 

Country:

China

Province:

Xinjiang

City:

单位(医院):

新疆昌吉回族自治州人民医院 

单位级别:

三甲 

Institution
hospital:

Xinjiang Changji Hui Autonomous Prefecture People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

 

Country:

China

Province:

Gansu

City:

单位(医院):

甘肃中医药大学附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Gansu University of traditional Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

 

Country:

China

Province:

Guangxi

City:

单位(医院):

广西医科大学第二附属医院 

单位级别:

三甲 

Institution
hospital:

The Second Affiliated Hospital of Guangxi Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆市中医院 

单位级别:

三甲 

Institution
hospital:

Chongqing Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

福建 

市(区县):

 

Country:

China

Province:

Fujian

City:

单位(医院):

福建省立医院 

单位级别:

三甲 

Institution
hospital:

Fujian Provincial Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆大学附属三峡医院 

单位级别:

三甲 

Institution
hospital:

Three Gorges Hospital Affiliated to Chongqing University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

 

Country:

China

Province:

Guangxi

City:

单位(医院):

广西壮族自治区人民医院 

单位级别:

三甲 

Institution
hospital:

The People's Hospital of Guangxi Zhuang Autonomous Region

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

 

Country:

China

Province:

Hebei

City:

单位(医院):

河北省精神卫生中心 

单位级别:

三甲 

Institution
hospital:

Mental Health Center of Hebei

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

吉林 

市(区县):

 

Country:

China

Province:

Jilin

City:

单位(医院):

吉林大学第一医院 

单位级别:

三甲 

Institution
hospital:

The First Hospital of Jilin University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

武汉市精神卫生中心 

单位级别:

三甲 

Institution
hospital:

Wuhan Mental Health Center

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

南方医科大学南方医院 

单位级别:

三甲 

Institution
hospital:

Nanfang Hospital of Southern Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

失眠缓解率

指标类型:

主要指标

Outcome:

Insomnia relief rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

治疗满意度

指标类型:

次要指标

Outcome:

Treatment satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集使用病例记录表,管理为电子管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected using case records and managed electronically.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-08-22 16:55:48